163 related articles for article (PubMed ID: 38689175)
1. Identification and targeting of metastatic biomarkers for hepatocellular carcinoma therapeutics using small molecules library of curcumin analogues.
Gupta A; Choudhary P; Singh S
Mol Divers; 2024 Apr; ():. PubMed ID: 38689175
[TBL] [Abstract][Full Text] [Related]
2. Brucine, an alkaloid from seeds of Strychnos nux-vomica Linn., represses hepatocellular carcinoma cell migration and metastasis: the role of hypoxia inducible factor 1 pathway.
Shu G; Mi X; Cai J; Zhang X; Yin W; Yang X; Li Y; Chen L; Deng X
Toxicol Lett; 2013 Oct; 222(2):91-101. PubMed ID: 23933019
[TBL] [Abstract][Full Text] [Related]
3. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
[TBL] [Abstract][Full Text] [Related]
4.
Yang YL; Tsai MC; Chang YH; Wang CC; Chu PY; Lin HY; Huang YH
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34206143
[TBL] [Abstract][Full Text] [Related]
5. Identification and Validation of TYMS as a Potential Biomarker for Risk of Metastasis Development in Hepatocellular Carcinoma.
Li S; Zhao J; Lv L; Dong D
Front Oncol; 2021; 11():762821. PubMed ID: 34858842
[TBL] [Abstract][Full Text] [Related]
6. Survivin in survival of hepatocellular carcinoma.
Su C
Cancer Lett; 2016 Sep; 379(2):184-90. PubMed ID: 26118774
[TBL] [Abstract][Full Text] [Related]
7. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
[TBL] [Abstract][Full Text] [Related]
8. Curcumin inhibits proliferation of hepatocellular carcinoma cells by blocking PTPN1 and PTPN11 expression.
Zhang J; Liu Y; Wang X; Wang Z; Xing E; Li J; Wang D
Oncol Lett; 2023 Jul; 26(1):307. PubMed ID: 37332329
[TBL] [Abstract][Full Text] [Related]
9. Long-term ethanol exposure-induced hepatocellular carcinoma cell migration and invasion through lysyl oxidase activation are attenuated by combined treatment with pterostilbene and curcumin analogues.
Huang CS; Ho CT; Tu SH; Pan MH; Chuang CH; Chang HW; Chang CH; Wu CH; Ho YS
J Agric Food Chem; 2013 May; 61(18):4326-35. PubMed ID: 23560895
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers.
Wang Y; Deng B
Cancer Metastasis Rev; 2023 Sep; 42(3):629-652. PubMed ID: 36729264
[TBL] [Abstract][Full Text] [Related]
11. RNA-binding protein RPS7 promotes hepatocellular carcinoma progression via LOXL2-dependent activation of ITGB1/FAK/SRC signaling.
Zhou YJ; Yang ML; He X; Gu HY; Ren JH; Cheng ST; Fu Z; Zhang ZZ; Chen J
J Exp Clin Cancer Res; 2024 Feb; 43(1):45. PubMed ID: 38326908
[TBL] [Abstract][Full Text] [Related]
12. Expression of USP22 and Survivin is an indicator of malignant behavior in hepatocellular carcinoma.
Tang B; Liang X; Tang F; Zhang J; Zeng S; Jin S; Zhou L; Kudo Y; Qi G
Int J Oncol; 2015 Dec; 47(6):2208-16. PubMed ID: 26497847
[TBL] [Abstract][Full Text] [Related]
13. Identification of significant gene and pathways involved in HBV-related hepatocellular carcinoma by bioinformatics analysis.
Xie S; Jiang X; Zhang J; Xie S; Hua Y; Wang R; Yang Y
PeerJ; 2019; 7():e7408. PubMed ID: 31392101
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of three core genes in p53 signaling pathway in hepatitis B virus-related hepatocellular carcinoma.
Yu M; Xu W; Jie Y; Pang J; Huang S; Cao J; Gong J; Li X; Chong Y
World J Surg Oncol; 2021 Mar; 19(1):66. PubMed ID: 33685467
[TBL] [Abstract][Full Text] [Related]
15. N-acetyl-galactosamine modified metal-organic frameworks to inhibit the growth and pulmonary metastasis of liver cancer stem cells through targeted chemotherapy and starvation therapy.
Hu J; Hu J; Wu W; Qin Y; Fu J; Zhou J; Liu C; Yin J
Acta Biomater; 2022 Oct; 151():588-599. PubMed ID: 36002126
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of hepatocellular carcinoma tumorigenesis by curcumin may be associated with CDKN1A and CTGF.
Zeng Y; Shen Z; Gu W; Wu M
Gene; 2018 Apr; 651():183-193. PubMed ID: 29408622
[TBL] [Abstract][Full Text] [Related]
17. The cell death-related genes machine learning model for precise therapy and clinical drug selection in hepatocellular carcinoma.
Du M; Qu Y; Qin L; Zheng J; Sun W
J Cell Mol Med; 2024 Apr; 28(7):e18168. PubMed ID: 38494848
[TBL] [Abstract][Full Text] [Related]
18. Lysyl oxidase induces epithelial-mesenchymal transition and predicts intrahepatic metastasis of hepatocellular carcinoma.
Umezaki N; Nakagawa S; Yamashita YI; Kitano Y; Arima K; Miyata T; Hiyoshi Y; Okabe H; Nitta H; Hayashi H; Imai K; Chikamoto A; Baba H
Cancer Sci; 2019 Jun; 110(6):2033-2043. PubMed ID: 30919528
[TBL] [Abstract][Full Text] [Related]
19. Identification of Hepatocellular Carcinoma-Related Potential Genes and Pathways Through Bioinformatic-Based Analyses.
Wan Z; Zhang X; Luo Y; Zhao B
Genet Test Mol Biomarkers; 2019 Nov; 23(11):766-777. PubMed ID: 31633428
[No Abstract] [Full Text] [Related]
20. MicroRNA-124-3p expression and its prospective functional pathways in hepatocellular carcinoma: A quantitative polymerase chain reaction, gene expression omnibus and bioinformatics study.
He RQ; Yang X; Liang L; Chen G; Ma J
Oncol Lett; 2018 Apr; 15(4):5517-5532. PubMed ID: 29552191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
